Literature DB >> 136826

Combined staging and grading of renal cell carcinoma.

P Hermanek, A Sigel, S Chlepas.   

Abstract

After surgical removal of renal cell cancers we can compare and contrast 3 prognostically differing groups by combining staging after Robson and histologic grading of malignancy. Good cancers (grade 1, stage I or II) have an (uncorrected) 5-year-survival rate of 93%, bad cancers (grade 3, Robson stage II or III) one of 35%. The remaining tumors (intermediate cancers) have a 5-year-survival rate of 64%. Classification in 3 groups is also advisable for future comparison of end result reports.

Entities:  

Mesh:

Year:  1976        PMID: 136826     DOI: 10.1007/bf00284376

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  5 in total

1.  THE SIGNIFICANCE OF CYTOPLASMIC GRANULARITY IN THE PROGNOSIS OF RENAL CELL CARCINOMA.

Authors:  G P MURPHY; F K MOSTOFI
Journal:  J Urol       Date:  1965-07       Impact factor: 7.450

2.  Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases.

Authors:  D G Skinner; R B Colvin; C D Vermillion; R C Pfister; W F Leadbetter
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

3.  Prognostic significance of renal vein invasion by hypernephroma.

Authors:  G H Myers; L G Fehrenbaker; P P Kelalis
Journal:  J Urol       Date:  1968-10       Impact factor: 7.450

4.  The results of radical nephrectomy for renal cell carcinoma.

Authors:  C J Robson; B M Churchill; W Anderson
Journal:  Trans Am Assoc Genitourin Surg       Date:  1968

5.  Histological grading of renal cell carcinoma.

Authors:  P Hermanek; A Sigel; S Chlepas
Journal:  Eur Urol       Date:  1976       Impact factor: 20.096

  5 in total
  1 in total

1.  [Morphogenesis and micromorphology of epithelial tumors induced in the rat kidney by nitrosomorpholine. II. Tubular glycogenosis and the genesis of clear or acidophilic cell tumors (author's transl)].

Authors:  P Bannasch; R Krech; H Zerban
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.